大蒜素联合氟胞嘧啶治疗慢性肺源性心脏病合并真菌性肺炎的临床效果探析

The Clinical Effect Observation of Garlicin and Flucytosine to Treat Chronic Pulmonary Heart Disease Complicated with Fungal Pneumoni

目的:探讨慢性肺源性心脏病合并真菌性肺炎的临床特点及不同方案治疗的临床效果。方法:选取2013年6月-2014年6月在广东省高州市石鼓镇中心卫生院接诊的78例慢性肺源性心脏病合并真菌性肺炎住院患者作为主要研究对象,采用随机性的方法,将本组试验患者分为两组,即观察组和对照组,每组39例,对照组患者接受氢氯噻嗪片、氟康唑胶囊联合使尔通治疗,在此基础上,给予观察组患者应用大蒜素软胶囊及氟胞嘧啶片治疗,对两组患者的临床治疗效果进行观察和比较。结果:通过对两组患者进行治疗,观察组患者的总有效率94.87%优于对照组71.79%,组间比较,差异具有统计学意义(P<0.05)。结论:在慢性肺源性心脏病合并真菌性肺炎的临床治疗过程中,大蒜素软胶囊及氟胞嘧啶片治疗的临床效果显著,不良反应较低。

Objective To observe the clinical effect of combined treatment of traditional Chinese and Western medicine and explore the curative methods for chronic pulmonary heart disease complicated with fungal pneumonia. Methods 78 cases of chronic pulmonary heart disease complicated with fungal pneumonia were chosen as the main research object, and were divided into two groups, the observation group and control group, 39 cases in each group. The control group received routine treatment of western medicine, while the observation group received Chinese medicine treatment, the clinical effect of the two groups were observed and compared. Results The total efficiency for observation group was 94.87 %, while for the control group was 71.79 %, the total effective rate of observation group was better than that of the control group, statistically significant differences between two groups （x^2 = 9.566, P 〈 0.05）. Conclusion The clinical effect of traditional Chinese combined with Western medicine to treat chronic pulmonary heart disease complicated with fungal pneumonia has remarkable effect, the adverse reaction is lower, which is worth the clinical promotion and use.